Saito T, Couzinet A, Suzuki T, Shimomura M, et al. Corrigendum to "Longitudinal monitoring of cellular immunity by the ex vivo activation of genes in leukocytes (EAGL) assay highlights potential markers of mRNA COVID-19 vaccine efficacy against breakthrough symptoms" [Vaccine 68 (2025) 127942]. Vaccine 2026;75:128267.
PMID: 41616652